SEARCH

Current Edition

Johnson & Johnson

Pressed by Wall Street, pharma executives signal openness to M&A

Pharmaceutical executives are getting asked the same question. With many large drugmakers flush with cash, and valuations of publicly traded biotech companies crashing, analysts on …

Continue Reading →